Abstract��OBJECTIVE To provide a reference to the use of quality standards in national drug sampling and testing, and establish the implementation plan. METHODS By carding the approval process and usage flow of drug standards, analyzing approval form, authorized department, revise and numbering methods of the standard, composition and influencing factors of standard serviceability were studied. RESULTS AND CONCLUSION The correctness and accuracy of the quality standards have a tremendous impact on national drug sampling and testing which is a significant measure of post-marketing surveillance. The article focuses on three aspects including the correctness, accuracy and orderliness, and then some solutions are proposed such as establishing the implementation plan and multi sector coordination, which can solve the problem of using standards in national drug sampling and testing.
��־��, ���»�, �쾼. ����ҩƷ�����ҩƷ�����������о�[J]. �й�ҩѧ��־, 2019, 54(3): 240-244.
GAO Zhi-feng, XIANG Xin-hua, ZHU Jiong. Research on the Applicability of Drug Quality Standards in National Drug Sampling and Testing. Chinese Pharmaceutical Journal, 2019, 54(3): 240-244.
WANG C, CHENG S H. Analysis and suggestion on effect of drug safety regulatory during national drug sampling and testing. Chin Pharm J (�й�ҩѧ��־),2016,51(20):1815-1818.
[2]
GAO Z F, LIN L. Integrated management mode of post-marketing quality evaluation of drugs . Chin J New Drugs(�й���ҩ��־),2017,26(1):29-31.
[3]
ZHU J L, YANG X, LI Z Y, et al. Development and prospect on the marketed drug sampling and testing for quality evaluation. Chin J New Drugs(�й���ҩ��־),2015,24(16):1810-1815.
[4]
National Institutes for Food and Drug Control. Annual report on National Drug Sampling and Testing in 2016 .[2017-10-09] (2018-07-03). http://www.nifdc.org.cn/CL0882/9872.html.
[5]
CHEN J, LI Z H, LI Y R, et al. Understanding of correct usage and implement of drug standards in drug analysis . Drug Stand China(�й�ҩƷ��),2009,10(4):253-255.
[6]
YAN J. Problems and solutions in the management of nation drug standards. J Shenyang Pharm Univ (����ҩ�ƴ�ѧѧ��), 2015, 32(8):651-653.
[7]
LIN Q. Analysis on effective management and verification of drug standards in institute for food and drug control . Drug Stand China(�й�ҩƷ��),2012,13(2):91-92.
[8]
ZHOU Z Q, YIN L J, WANG N L. How to find the standard of drug quality according to the standard number . China Pharm(�й�ҩҵ),2015,24(4):3-4.
[9]
China Food and Drug Administration. Notice on issuing regulations for the check and inspection of drug quality. [2006-07-21] (2018-07-03). http://samr.cfda.gov.cn/WS01/CL0844/10583.html.
[10]
China Food and Drug Administration. Provisions for drug registration . [2007-07-10] (2018-07-03). http://samr.cfda.gov.cn/WS01/CL0053/24529.html.
[11]
JIANG X P. Strategies for developing Chinese drug standards from the Chinese Pharmacopoeia 2010 edition. Chin Pharm J(�й�ҩѧ��־),2010,45(17):1281-1283.
[12]
ZHANG W, LAN F, HONG X X. Overview on the Chinese Pharmacopoeia 2015 edition . Chin Pharm J(�й�ҩѧ��־),2010,45(17):1743-1746.
[13]
ZHANG W. Study on drug standards and drug quality . Drug Stand China(�й�ҩƷ��),2016,17(1):3-9.
[14]
GAO Z F, YANG H X. Study on electronic management for drug inspection standards. China Pharm(�й�ҩʦ),2014,17(4):665-666.
[15]
HUANG B B, YANG Q Y, XU M Z, et al. Review on management of supplementary testing method and items and recommendations for future development . Chin Pharm Aff(�й�ҩ��),2014,28(5):453-456.
[16]
JIA C, LI J H, ZHU L. Investigation and analysis of implementation standards in the 471 batch of drug instructions . China Pharm(�й�ҩʦ),2010,13(10):1508-1510.
[17]
LU J H. Investigation and analysis on the implementation of standard instructions in 1 066 drug package inserts . Chin J Rational Drug Use(�й�������ҩ̽��),2017,14(1):38-41.
[18]
CAI H, DU S M. Status of drug execution standards in 84 traditional Chinese medicine injections. Her Med(ҽҩ����),2014, 33(1):125-127.
[19]
Chinese Pharmacopoeia Commission. Interpretation of issues related to the implementation of the Chinese Pharmacopoeia 2015 edition . [2015-12-03] (2018-07-03). http://www.chp.org.cn/view/ff808081527bfe270154083b2e6952cf?a=GZWJ.
[20]
Chinese Pharmacopoeia Commission. Introduction of National Drug Standards. . [2015-07-29](2018-07-03). http://www.chp.org.cn/view/ff8080814ed3fb6e014ed87a0c070360?a=YDXTS.
[21]
China Food and Drug Administration. Announcement on the implementation of the Chinese Pharmacopoeia 2015 edition. . [2015-07-15] (2018-07-03). http://samr. cfda. gov. cn/WS01/CL0087/124440. html.
[22]
Chinese Pharmacopoeia Commission. Notice on issuing corrigendum of the Chinese Pharmacopoeia 2015 edition. . [2015-12-03] (2018-07-03). http://www.chp.org.cn/view/ff80808151622d9f01516706766304f3?a=f2.
[23]
Chinese Pharmacopoeia Commission. Notice on issuing corrigendum of the Chinese Pharmacopoeia 2015 edition (the second times). . [2016-02-22] (2018-07-03). http://www.chp.org.cn/view/ff808081527bfe27015306e2fc961ec9?a=f2.
[24]
Chinese Pharmacopoeia Commission. Notice on issuing corrigendum of the Chinese Pharmacopoeia 2015 edition (the third times). . [2016-08-23] (2018-07-03). http://www.chp.org.cn/view/ff808081559d1ea30156b30e8bf734b4?a=KWHXYP.
[25]
TIAN J, ZHANG Z F. Main problems and analysis of modification of registration specifications in the supplementary application . Chin J New Drugs(�й���ҩ��־),2014,23(10):1118-1120.
[26]
GAO Z F, LIN L, YANG H X. Research on the theoretical basis to the drug emergency inspection management. Chin J Pharmacovigilance(�й�ҩ�ﾯ��),2014,11(4):216-218.
[27]
GAO Z F, LIN L. Research on the validity of standards in drug inspection . Chin J New Drugs(�й���ҩ��־),2017,26(3):261-263.
[28]
GAO Z F, ZHANG Q M. Describe the thought and practice of drug standards management . China Pharm(�й�ҩʦ),2012,15(10):1515-1515.
[29]
GAO Z F, ZHANG Q M, YANG H X. Describe the management of pharmaceutical standards in NIFDC. Chin Pharm Aff(�й�ҩ��),2012,26(8):873-874.
2019, Vol. 54 
